Valencia Technologies Corporation, a medical technology corporation, currently holds a patent for subcutaneous neuromodulation system (SNS), which emits a low-powered electrical stimulus that communicates with the brain to help regulate blood pressure.
Building on this technology, the company has now been assigned a patent for an implantable electroacupuncture device (IEAD) for treating erectile dysfunction.
The device is coin-sized, self-contained, leadless, and has at least two electrodes attached to an outside surface of its housing. It works by applying electroacupuncture (EA) stimulation pulses at various “target tissue locations.”
According to the patent, “The device generates stimulation pulses in accordance with a specified stimulation regimen. Power management circuitry within the device allows a primary battery, having a high internal impedance, to be used to power the device.”
Its low duty cycle and power management allow the IEAD to perform its intended function for several years – meaning no more pills.